INTRODUCTION
S caling and root planing disperse bacterial plaque and arrest the progression of periodontitis in many individuals. However, refractory and aggressive forms of periodontitis may be resistant to this treatment, because the associated pathogens (Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis) are capable of invading epithelial cells lining the pocket or gingival crevice (Christersson et al., 1987; Lamont et al., 1995; Fives-Taylor et al., 1996) . In this manner, invasive pathogens can evade the host response and gain access to nutrients inside the host. Antimicrobial agents are frequently used as adjuncts to help eliminate these bacteria. Fluoroquinolones and tetracyclines are particularly useful because they can penetrate epithelial cells. Fluoroquinolones are highly efficient in killing A. actinomycetemcomitans, while tetracyclines are capable of inhibiting both A. actinomycetemcomitans and P. gingivalis (Pavicic et al., 1992; van Winkelhoff et al., 1996) . Interestingly, both classes of antibiotics appear to distribute preferentially in the gingival fluid (GF). When taken by the systemic route, tetracyclines attain GF levels that are approximately four-to five-fold higher than serum levels, while ciprofloxacin reaches GF levels that are about 4.5-fold higher (Ciancio et al., 1980; Pascale et al., 1986; Conway et al., 2000) .
Little is known about the mechanisms by which these agents concentrate in GF. Since polymorphonuclear leukocytes (PMNs) take up and accumulate ciprofloxacin and other fluoroquinolones (Easmon and Crane, 1985; Garraffo et al., 1991; Perea et al., 1992) , it has been suggested that they might carry ciprofloxacin with them as they migrate to inflamed periodontal sites. In support of this hypothesis, recent studies demonstrated that root planing results in a small (10%), but statistically significant, decrease in GF ciprofloxacin levels at sites that initially exhibit inflammation. However, GF ciprofloxacin levels are still several-fold higher than serum levels, even in subjects with healthy gingiva (Conway et al., 2000) . This suggests that inflammation is not the major determinant of fluoroquinolone accumulation in GF.
GF originates from the vessels of the gingival plexus, seeps through the connective tissue, and passes through the junctional epithelium (Schroeder and Listgarten, 1997) . Since the junctional epithelium is a relatively leaky epithelial barrier (Schroeder, 1981) , it probably does not play a role in concentrating antimicrobial agents in the GF. We hypothesize that fibroblasts in the gingival connective tissue accumulate fluoroquinolones and tetracyclines, thereby enhancing their redistribution to gingiva and increasing their levels in GF. Our results support this hypothesis and provide a better understanding of the distribution of these agents in the gingiva.
MATERIALS & METHODS

Isolation and Culture of Gingival Fibroblasts
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protocol and with an informed consent procedure approved by the Institutional Review Board. Cells were cultured at 37°C in 5% CO 2 in minimal essential medium (MEM, Life Technologies Inc., Rockville, MD, USA) supplemented with 2 mM glutamine and 10% heat-inactivated fetal bovine serum. For the experiments described below, fibroblasts were seeded into 24-well cell culture plates and fed every 3 days until they formed a confluent monolayer. Cells were used between passage numbers 4 and 15.
Assay of Fluoroquinolone and Tetracycline Transport
We assayed transport by measuring cell-associated fluoroquinolone or tetracycline fluorescence. Multiwell culture plates containing confluent cell monolayers were washed 4x with Hanks' balanced salts solution (HBSS), overlaid with 0.2 mL/well HBSS, and warmed to 37°C prior to assay. In the ciprofloxacin transport assays, 0.2 mL of warm HBSS containing twice the desired final fluoroquinolone concentration was simultaneously added to each well with multichannel pipettes. After incubation at 37°C for the indicated times, the fluoroquinolone solutions were quickly removed. Using the cluster-tray method described by Gazzola et al. (1981) , we rapidly washed each well 4x with HBSS, to eliminate extracellular antibiotics. Cell monolayers were lysed in 1 mL of 100 mM glycine (pH 3.0) with a scraper. The lysate was centrifuged at 13,000 x g for 6 min, and its fluorescence was measured as previously described (Walters et al., 1999) .
Transport of tetracyclines was assayed by a similar approach, except that the cells were lysed in 1 mL of water. For minocycline, the lysate was added to 1 mL of ethylene glycol containing 200 mM citric acid and 200 mM magnesium acetate prior to measurement of the fluorescence (Lever, 1972) . We constructed calibration plots to relate fluorescence to cell antibiotic content, which was normalized to cell protein by the method of Bradford (1976) .
To determine the affinity and velocity of transport, we measured the kinetics of transport during the linear initial phase (0 to 3 min) and analyzed it by the Lineweaver-Burk method. EnzPack for Windows (Biosoft, Ferguson, MO, USA) was used to derive the Michaelis constant (K m ) and maximum transport velocity (V max ) values from regression lines obtained with the plotted data. Several organic cations inhibited transport and altered the Lineweaver-Burk plot intercepts. The pattern of alterations produced by these agents was used to determine the mechanism of inhibition and the inhibition constant (K i ).
Intracellular Volume Measurements
To calculate intracellular antibiotic concentrations, we divided the intracellular content by intracellular volume. We measured the latter by equilibrating fibroblast suspensions with [ 3 H]-water (5 Ci/mL, NEN Life Science Products) (Garraffo et al., 1991) . After incubation for 10 min, cells were rapidly pelleted through oil as previously described (Walters et al., 1999) . The pellet was lysed and counted with a liquid scintillation system. To correct for the extracellular water trapped in the pellet, we equilibrated cells with [ 14 C]-inulin (2 Ci/mL, NEN Life Science Products) and processed them similarly.
RESULTS
Gingival fibroblasts accumulated ciprofloxacin and minocycline in a saturable and temperaturedependent manner (Fig. 1) . Uptake of both agents was strongly inhibited at 4°C. Their kinetics yielded linear plots when analyzed by the Lineweaver-Burk method. Ciprofloxacin was transported with a K m of 200 g/mL at a V max of 4.62 ng/min/g cell protein (Table 1) . Ofloxacin and moxifloxacin were transported with similar affinity, but the To determine the effect of pH on transport, the kinetics of uptake was analyzed between pH 6.2 and 8.2 (Fig. 2, top) . Changes in pH had a significant effect on the efficiency of transport (assessed by the V max /K m ratio; P < 0.05, ANOVA). Transport of both agents was most efficient at pH 7.2, but V max /K m decreased by nearly 35% at pH 6.2 (P < 0.05, Dunnett's test for both) and 25% at pH 8.2 (P < 0.05 for ciprofloxacin). We further characterized the transporters by comparing transport activity in the presence and absence of sodium. Elimination of sodium failed to block the transport of ciprofloxacin or minocycline.
Fibroblasts loaded with ciprofloxacin or minocycline rapidly lost much of their antibiotic content when the concentration of antibiotics in the extracellular medium was abruptly diluted (Fig. 2, bottom) . The rate of efflux was similar for both antimicrobial agents. Approximately half the cellular antimicrobial content was lost within 45 sec, and nearly 80% was lost within 15 min.
We performed inhibition studies with a variety of organic cations to determine whether the transporters of ciprofloxacin and minocycline are similar in their susceptibility to inhibition. Adenine competitively inhibited the transport of ciprofloxacin and minocycline, with K i values of 1.36 and 1.75 mm, respectively (Table 2) . Diazepam failed to inhibit ciprofloxacin transport at a concentration of 2 mM, but was a potent competitive inhibitor of minocycline transport (K i = 0.88 mM). Phenylephrine, pyrilamine, papaverine, and tetracycline inhibited ciprofloxacin transport through a non-competitive mechanism, but produced competitive inhibition of minocycline transport. Penicillin (5 mM) did not significantly inhibit the transport of ciprofloxacin or minocycline (not shown).
DISCUSSION
Human gingival fibroblasts express saturable transporters that allow them to take up extracellular fluoroquinolones and tetracyclines and act as reservoirs for these agents in the gingiva. Although the affinity of forward transport is relatively low, fibroblasts accumulate remarkable amounts of minocycline and ciprofloxacin. The observed cellular/extracellular concentration (C/E) ratios were > 60 for minocycline and > 8 for ciprofloxacin. Consistent with these observations, the efficiency of minocycline transport (assessed by V max /K m ) is about six times higher than for ciprofloxacin. Minocycline's K m for transport is half that of ciprofloxacin, and its transport velocity is approximately three times higher.
In addition to the differences in efficiency, transporters of ciprofloxacin and minocycline differ in their susceptibility to inhibition by other organic cations. Phenylephrine, pyrilamine, tetracycline, and papaverine produced competitive inhibition of minocycline transport but acted as noncompetitive inhibitors of ciprofloxacin transport. In contrast, diazepam produced competitive inhibition of minocycline transport (K i = 0.9 mM), but failed to inhibit ciprofloxacin transport at this concentration. Penicillin did not inhibit the transport of ciprofloxacin or minocycline. It is not preferentially concentrated in gingival fluid and does not appear to share a path of uptake with these two agents. The only agent that produced competitive inhibition of both transport processes was adenine. This suggests that transport of minocycline (which possesses primary and tertiary amines) is mediated by a system with broad substrate specificity. The organic cation transporter family may play a role, since it is widely distributed and accepts a broad range of cationic substrates (Koepsel, 1998; Dresser et al., 1999) . Ciprofloxacin is a multi-ring Changes in pH produced a significant overall effect on ciprofloxacin transport (P < 0.02, ANOVA). Treatments that produced a significant difference from pH 7.2 are indicated by * (P < 0.05, Dunnett's test). Lower panel: Cell monolayers were loaded to steady-state by incubation for 20 min at 37°C in HBSS containing 50 g/mL ciprofloxacin or minocycline.
To trigger antibiotic efflux from the loaded cells, we diluted extracellular antimicrobial solutions 1:20 with 37°C HBSS. Efflux was monitored by the decrease in cell-associated fluorescence. compound that shares some structural features with purines. It could potentially interact with nucleobase or nucleoside transporters, since adenine competitively inhibits its transport. These transporters normally take up precursors for the synthesis of nucleic acids and ATP (Griffith and Jarvis, 1996) . PMNs and certain epithelial cell lines have been shown to accumulate fluoroquinolones and achieve C/E ratios similar to those observed in fibroblasts in this study (Pascual et al., 1997 (Pascual et al., , 1999 . Gingival fibroblasts, monocytes, and resting PMNs appear to take up ciprofloxacin with similar affinity, comparable pH and sodiumdependence, and susceptibility identical to competitive inhibition by adenine (Walters et al., 1999; Bounds et al., 2000) . With tetracyclines, however, fibroblasts attain a C/E ratio that is at least 10-fold higher than that reported for PMNs (Gabler, 1991) .
Transporters are capable of moving their substrates in the forward or reverse direction to maintain equilibrium between intracellular and extracellular concentrations. For this reason, intracellular stores of ciprofloxacin and minocycline move out of gingival fibroblasts when their concentrations decrease in the extracellular medium (Fig. 2,  bottom panel) . During antimicrobial therapy in vivo, forward transport predominates during periods in which these agents are increasing or peaking in the blood (typically 2 to 3 hrs after administration). As antibiotic levels in the blood and tissue decrease from their peak values, net transport changes to the reverse direction. Efflux from gingival fibroblasts could potentially maintain relatively high antimicrobial levels in the interstitial fluid as blood levels decrease. Due to the unique architecture of the gingiva (Schroeder and Listgarten, 1997) , much of the ciprofloxacin or minocycline in interstitial fluid is eventually washed through the junctional epithelium and into the gingival crevice. The existence of a drug reservoir in the gingiva could explain why tetracycline (Gordon et al., 1981) , doxycycline (Pascale et al., 1986) , minocycline (Ciancio et al., 1980) , and ciprofloxacin (Conway et al., 2000) appear to reach higher levels in GF than in blood serum when sampled after blood levels have receded from their peak values. It could also account for the findings of Sakellari et al. (2000) , who found higher levels of tetracycline, doxycycline, and minocycline in blood than in GF. Their blood and GF samples were obtained 2 hrs after oral administration, which coincides with or precedes the time of peak blood levels.
In summary, this study has begun to characterize transport systems that influence the effectiveness of periodontal antimicrobial chemotherapy. The results suggest that gingival fibroblasts can function as reservoirs for fluoroquinolones and tetracyclines. Their ability to accumulate high levels of these agents may enhance their redistribution from the bloodstream to the gingiva and contribute to increased antibiotic levels in GF.
